上海交大赵大海接受央视专访:中国向全球提供新冠疫苗是践行人类命运共同体的重要体现


上海交通大学国际与公共事务学院博士生导师、上海交通大学-耶鲁大学卫生政策联合研究中心执行主任赵大海,自新冠肺炎疫情暴发以来,对于新冠疫情暴发、防控以及卫生政策第47次接受上海电视台专访,也是第73次接受央视、上视专访。2020年12月23日,赵大海在中央电视台英语频道的《中国24小时》节目,就中国新冠疫苗的分配方案和向各国提供新冠疫苗等话题进行了直播访谈。现将访谈内容翻译并摘录如下。

主持人:中国计划首先针对高危人群接种新冠疫苗。特别是英国出现了一种新的冠状病毒株之后,您对中国的新冠疫苗接种计划有何看法?这一计划将如何帮助进一步降低中国再次出现新冠疫情的风险?

赵大海:鉴于在短时间内,新冠疫苗产量有限,重点人群,即感染新冠病毒风险较高的人群优先接种疫苗;我相信中国的新冠疫苗的分配和接种策略是公平和合乎伦理道德的。实际上,确实没有更好的办法来解决新冠疫苗的分配问题。考虑到高危或重点人群已接种了新冠疫苗,新冠病毒局部暴发或死灰复燃的风险就必然将大大降低。虽然近几个月来,中国大陆绝大多数地区都没有新的新冠确诊病例,但新冠疫情局部暴发和死灰复燃的风险仍然存在而且较大。因此,我强烈建议中国所有重点人群接种新冠疫苗。


主持人:中国已经加入了由世界卫生组织共同领导的全球新冠肺炎疫苗实施计划。您如何看待中国在这项计划中的作用?

赵大海:中国在该倡议中的作用是,正是因为中国加入COVAX,才使该倡议真正具有意义。由于在COVAX的成员当中,中国是唯一的现在有能力生产新冠疫苗的国家;如果中国不加入,COVAX将变得毫无意义。中国在这一倡议中的作用,将为参与这一倡议的国家提供大量的新冠疫苗,真正有助于实现新冠疫苗在全球范围内公平分配的目标。中国加入COVAX真正践行了人类命运共同体的理念,是全球共同抗击新冠肺炎疫情最好的榜样。总之,中国在这项计划或倡议当中起到的是决定性作用,对全球共同抗击新冠大流行也起到的是决定性作用。与此同时,世界各国也期盼现在能生产新冠疫苗的其他国家共同为各国提供新冠疫苗。

供稿者:上海交通大学

日期:2020年12月23日


Dahai ZHAO’s Exclusive Interview with CGTN: China's provision of COVID-19 vaccines to the world is an important manifestation of the vision of a community with a shared future for mankind

Dahai Zhao, a doctoral supervisor at the School of International and Public Affairs of Shanghai Jiao Tong University and Executive Director of Shanghai Jiao Tong University-Yale University Joint Research Center for Health Policy, has been interviewed by CGTN for the 47nd time (the 73nd time by CGTN / ShanghaiTV) since the COVID-19 pandemic. On December 23, 2020, Zhao commented on China's COVID-19 vaccine distribution programme and the provision of COVID-19 vaccine to some countries on “China 24” of CGTN.

Anchor: What's your take on China's plan to target high-risk groups first for inoculation against COVID-19, especially in the light of a new coronavirus strain that's emerged from the UK, and how will this plan help further lower the risk of a resurgence in China?

ZHAO: Due to the fact that the limited production of COVID-19 vaccines in the near future, key population those who have the higher risk of being infected by COVID-19 virus have the priority of being vaccinated. I believe the strategy of distribution on COVID-19 vaccines is fair and ethical. Actually, there is no better solutions to solve the distribution issues. Considering the high-risk population having been vaccinated, the risk of local outbreak or resurgence of COVID-19 will be dramatically decreased. Although there have been no new confirmed cases in the most majority of areas in Chinese mainland for a couple of months, the risk of local outbreak and resurgence still exist. Therefore, I strongly suggest that all high-risk population in China should vaccinate the COVID-19 vaccines.

Anchor: China has joined the COVAX global initiative co-led by the W-H-O for vaccine distribution. What do you make of China's role in the initiative?

ZHAO: China’s role in the initiative is that China’s joining COVAX makes this initiative meaningful. Due to the fact that China is the only one country that have the capacity to produce the current COVID-19 vaccines among all countries in the COVAX, if China did not join, the COVAX would become meaningless. China’s role in this initiative and will offer a large number of COVID-19 vaccines to the countries in this initiative, really help to realize the goal of fair distribution of COVID-19 vaccine at the global level. China’s joining COVAX absolutely shows China’s ideology of Community of shared future for human being, and the best example for combating COVID-19 in the world. In a word, China plays determining role in the CVOAX and combating the pandemic of COVID-19 in the world. 

Contributor: SIPA, SJTU

Data: December 23, 2020


沪交ICP备20200053
Copyright © 2020上海交大—耶鲁大学卫生政策联合研究中心/SJTU-Yale Joint Center for Health Policy